A randomized, open-label clinical trial comparing the long-term effects of miltefosine and meglumine antimoniate for mucosal leishmaniasis
Abstract INTRODUCTION: The treatment of mucosal leishmaniasis (ML) is difficult due to the toxicity and route of administration of standard drugs. Miltefosine is an oral agent used for leishmaniasis treatment; however, no data exist regarding its use for ML in Brazil. In this study, we aimed to ev...
Main Authors: | Raimunda Nonata Ribeiro Sampaio, Juliana Saboia Fontenele e Silva, Carmen Dea Ribeiro de Paula, Cláudia Porto, Jorgeth de Oliveira Carneiro da Motta, Ledice Inacia de Araujo Pereira, Sofia Sales Martins, Daniel Holanda Barroso, Gustavo Subtil Magalhães Freire, Ciro Martins Gomes |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Medicina Tropical (SBMT)
2019-03-01
|
Series: | Revista da Sociedade Brasileira de Medicina Tropical |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822019000100315&lng=en&tlng=en |
Similar Items
-
A Pilot Randomized Clinical Trial: Oral Miltefosine and Pentavalent Antimonials Associated With Pentoxifylline for the Treatment of American Tegumentary Leishmaniasis
by: Sofia Sales Martins, et al.
Published: (2021-07-01) -
COMPARISON OF ORAL CHLOROQUINE WITH SYSTEMIC MEGLUMINE ANTIMONIATE IN TREATMENT OF CUTANEOUS LEISHMANIASIS
by: Muhammad Farooq, et al.
Published: (2021-02-01) -
A retrospective cohort study of the effectiveness and adverse events of intralesional pentavalent antimonials in the treatment of cutaneous leishmaniasis
by: Bruna Côrtes Rodrigues, et al.
Published: (2020-12-01) -
FACTORS ASSOCIATED TO ADHERENCE TO DIFFERENT TREATMENT SCHEMES WITH MEGLUMINE ANTIMONIATE IN A CLINICAL TRIAL FOR CUTANEOUS LEISHMANIASIS
by: Madelon Novato Ribeiro, et al.
Published: (2014-07-01) -
Pentavalent Antimonials: New Perspectives for Old Drugs
by: Raul R. Ribeiro, et al.
Published: (2009-06-01)